Alexion Pharma (Switzerland)

Alexion Pharma (Switzerland)

Alexion Pharmaceuticals is an American pharmaceutical company headquartered in Boston, Massachusetts that specializes in orphan drugs to treat rare diseases. It became a subsidiary of AstraZeneca in 2021. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for Alexion Pharma (Switzerland), Switzerland, covering academic research published from 2000 to 2021. Read More.


Open Access Percentage

60%


Total
Publications

532


Total Open
Publications

321


Total
Citations

19K


Open Access
Percentage

60%


Total
Publications

532


Total Open
Publications

321


Total
Citations

19K

Wikipedia

Website

Download

Breakdown

17% 35% 8% 40%

Publisher Open

17%

Both

35%

Other Platform Open

8%

Closed

40%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

05101520253035404550556065Total Publications
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021

Open

Closed

Publisher Open

35%OA Journal

OA Journal 35%

97

Hybrid 29%

82

No Guarantees 36%

101

Other Platform Open

Domain 89%

204

Institution 39%

89

Public 4%

10

Other Internet 3%

8

Preprint 3%

6

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
204
Europe PMC
Domain
143
Ghent University - Ghent University Academic Bibliography
Institution
26
Semantic Scholar
Public
10
KU Leuven - Lirias
Institution
10
Newcastle Univesity - Newcastle University ePrints
Institution
6
uniroma1.it OAI-PMH Repository
Institution
5
DANS - Data Archiving and Networked Services - NARCIS - National Academic Research and Collaborations Information System
Institution
5
University of Florence - Florence Research
Institution
4
Le Centre pour la Communication Scientifique Directe - HAL - Archive ouverte HAL
Institution
4
1 / 8

Data updated 27 September 2022

Share

Share

Share